Tianjin Cord Blood Hematopoietic Stem Cell Bank

Tianjin Cord Blood Hematopoietic Stem Cell Bank is a specialized healthcare institution and one of the seven licensed cord blood banks authorized by the National Health Commission of China. Established in 2001, the bank focuses on the collection, processing, and long-term cryopreservation of hematopoietic stem cells derived from umbilical cord blood. These cells are utilized in the treatment of over 80 life-threatening diseases, including various forms of leukemia, lymphoma, and inherited metabolic disorders. The facility operates under strict GMP standards and is a key subsidiary of Vcanbio Cell & Gene Engineering. In addition to its storage services, the bank collaborates with medical institutions to support clinical research and the application of stem cell therapies in regenerative medicine. It serves as a vital resource for both public donation and private family banking in the North China region.